original articlesgastrointestinal tumorsCapecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy
gastrointestinal tumors
Under an Elsevier user license
open archive
Keywords
5-fluorouracil/folinic acid
adjuvant therapy
capecitabine
colon cancer
elderly
pharmacodynamic markers
Cited by (0)
Copyright © 2012 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.